Literature DB >> 23108049

DUSP6 is a novel transcriptional target of p53 and regulates p53-mediated apoptosis by modulating expression levels of Bcl-2 family proteins.

Sujan Piya1, Ji Young Kim, Jeehyeon Bae, Dai-Wu Seol, Ae Ran Moon, Tae-Hyoung Kim.   

Abstract

p53 regulates various cellular responses through transcriptional regulation of distinct sets of target genes. Dual specificity phosphatase 6 (DUSP6) is a cytosolic phosphatase that inactivates the extracellular-signal-regulated kinase 1/2 (ERK1/2). This study demonstrates that p53 transactivates DUSP6 in human colorectal HCT116 cells to regulate ERK1/2 in p53-mediated cell death. DUSP6 is transactivated by p53 overexpression and genotoxic agents, and chromatin immunoprecipitation revealed two p53-binding sites in the DUSP6 promoter responsible for DUSP6 induction. Expression of shDUSP6 inhibited 5'-FU-induced cell death, whereas overexpression of DUSP6 increased susceptibility to 5'-FU. 5'-FU treatment dephosphorylated ERK in a DUSP6-dependent manner, resulting in destabilization of Bcl-2 and stabilization of Bad. These results provide insights on the modulatory role of p53 in the survival pathway by up-regulating DUSP6.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108049     DOI: 10.1016/j.febslet.2012.10.031

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study.

Authors:  Hongming Song; Chenyang Wu; Chuankui Wei; Dengfeng Li; Kaiyao Hua; Jialu Song; Hui Xu; Lei Chen; Lin Fang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  p53 protein-mediated up-regulation of MAP kinase phosphatase 3 (MKP-3) contributes to the establishment of the cellular senescent phenotype through dephosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2).

Authors:  Hui Zhang; Yuan Chi; Kun Gao; Xiling Zhang; Jian Yao
Journal:  J Biol Chem       Date:  2014-11-20       Impact factor: 5.157

3.  Therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia using Fe₂O₃ nanoparticles.

Authors:  S Y Yan; M M Chen; J G Fan; Y Q Wang; Y Q Du; Y Hu; L M Xu
Journal:  Braz J Med Biol Res       Date:  2014-08-29       Impact factor: 2.590

4.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Genetic Pathways of Neuroregeneration in a Novel Mild Traumatic Brain Injury Model in Adult Zebrafish.

Authors:  Amanda L Maheras; Brian Dix; Olivia M S Carmo; Aleena E Young; Vanessa N Gill; Julia L Sun; Aleah R Booker; Helen A Thomason; Anastasia E Ibrahim; Lauren Stanislaw; Jennifer C Dallego; Cat N Ngo; Audrey Chen; Barbara K Fortini; Rory D Spence
Journal:  eNeuro       Date:  2018-01-03

6.  microRNA-200a-3p increases 5-fluorouracil resistance by regulating dual specificity phosphatase 6 expression.

Authors:  Heejin Lee; Chongtae Kim; Hoin Kang; Hyosun Tak; Sojin Ahn; Sungjoo Kim Yoon; Hyo-Jeong Kuh; Wook Kim; Eun Kyung Lee
Journal:  Exp Mol Med       Date:  2017-05-12       Impact factor: 8.718

Review 7.  Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?

Authors:  Ignacio Campillo-Marcos; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2018-04-20       Impact factor: 9.261

8.  DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.

Authors:  Lars Tögel; Rebecca Nightingale; Rui Wu; Anderly C Chüeh; Sheren Al-Obaidi; Ian Luk; Mercedes Dávalos-Salas; Fiona Chionh; Carmel Murone; Daniel D Buchanan; Zac Chatterton; Oliver M Sieber; Diego Arango; Niall C Tebbutt; David Williams; Amardeep S Dhillon; John M Mariadason
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

9.  Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.

Authors:  Muhammad Khairi Ahmad; Nur Ainina Abdollah; Nurul Husna Shafie; Narazah Mohd Yusof; Siti Razila Abdul Razak
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

10.  Guzhi Zengsheng Zhitongwan, a Traditional Chinese Medicinal Formulation, Stimulates Chondrocyte Proliferation through Control of Multiple Genes Involved in Chondrocyte Proliferation and Differentiation.

Authors:  Baojin Yao; Bocheng Lu; Hongwei Gao; Mei Zhang; Xiangyang Leng; Daqing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.